Myomo (MYO) Capital Expenditures (2017 - 2025)
Myomo (MYO) reported Capital Expenditures of $1.1 million for Q3 2025, up 228.3% on a YoY basis from $320704.0 in Q3 2024, and down 45.39% quarter-over-quarter from $1.9 million in Q2 2025.
Myomo (MYO) Capital Expenditures (2017 - 2025) Analysis & Trends
Myomo has reported Capital Expenditures for 9 years, with the latest figure at $1.1 million in Q3 2025.
- For the quarter ending Q3 2025, Capital Expenditures rose 228.3% year-over-year to $1.1 million; the trailing twelve-month figure through Sep 2025 stood at $3.8 million (up 622.64% YoY), and the FY2024 full-year result was $1.4 million, up 832.77% from the prior year.
- Capital Expenditures for Q3 2025 stood at $1.1 million, down from $1.9 million in the prior quarter.
- The five-year high for Capital Expenditures was $1.9 million in Q2 2025, with the low at $3385.0 in Q4 2022.
- Historically, Capital Expenditures has averaged $273616.0 across 5 years, with a median of $53443.0 in 2022.
- Annual changes were most pronounced in 2022 — Capital Expenditures tumbled 89.55% — and 2024, when it soared 2616.72%.
- Myomo's Capital Expenditures stood at $23935.0 in 2021, then slumped by 85.86% to $3385.0 in 2022, then surged by 835.45% to $31665.0 in 2023, then soared by 2616.72% to $860248.0 in 2024, then advanced by 22.39% to $1.1 million in 2025.
- The last three Capital Expenditures figures came in at $1.1 million (Q3 2025), $1.9 million (Q2 2025), and $860248.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.05 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Dec 31, 2024 | 860,248.00 |
| Dec 31, 2024 | 860,248.00 |
| Sep 30, 2024 | 320,704.00 |
| Sep 30, 2024 | 320,704.00 |
| Jun 30, 2024 | 119,365.00 |
| Jun 30, 2024 | 119,365.00 |
| Mar 31, 2024 | 59,808.00 |
| Mar 31, 2024 | 59,808.00 |
| Dec 31, 2023 | 31,665.00 |
| Dec 31, 2023 | 31,665.00 |
| Sep 30, 2023 | 54,093.00 |
| Sep 30, 2023 | 54,093.00 |
| Jun 30, 2023 | 14,973.00 |
| Jun 30, 2023 | 14,973.00 |
| Mar 31, 2023 | 45,085.00 |
| Mar 31, 2023 | 45,085.00 |